These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)]. de la Fouchardière A; Vergier B Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446 [No Abstract] [Full Text] [Related]
50. Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation. Kelly JW; Crutcher WA; Sagebiel RW J Am Acad Dermatol; 1986 Jun; 14(6):1044-52. PubMed ID: 3722481 [TBL] [Abstract][Full Text] [Related]
51. Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: an immunohistological assessment in human skin. Reichrath J; Seyfried P; Braun R; Müller SM; Baum HP; Bahmer FA Dermatology; 1997; 194(2):136-9. PubMed ID: 9094461 [TBL] [Abstract][Full Text] [Related]
52. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree. Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833 [No Abstract] [Full Text] [Related]
53. Melanoma in a 5-year-old child with a giant congenital melanocytic naevus. Surrenti T; Diociaiuti A; Inserra A; Accinni A; Giraldi L; Callea F; El Hachem M Acta Derm Venereol; 2012 Nov; 92(6):607-8. PubMed ID: 22334027 [No Abstract] [Full Text] [Related]
54. BAP1 deficient malignant melanoma arising from the intradermal component of a congenital melanocytic naevus. Ardakani NM; Palmer DL; Wood BA Pathology; 2015 Dec; 47(7):707-10. PubMed ID: 26517632 [No Abstract] [Full Text] [Related]
55. Familial site-specific congenital melanocytic nevus: report of two families. Frieden IJ; Williams ML Arch Dermatol; 1994 Aug; 130(8):1075-6. PubMed ID: 8053712 [No Abstract] [Full Text] [Related]
56. Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. Greene MH; Clark WH; Tucker MA; Elder DE; Kraemer KH; Guerry D; Witmer WK; Thompson J; Matozzo I; Fraser MC N Engl J Med; 1985 Jan; 312(2):91-7. PubMed ID: 3964923 [No Abstract] [Full Text] [Related]
57. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy. Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384 [TBL] [Abstract][Full Text] [Related]
58. The Skin Molecular Ecosystem Holds the Key to Nevogenesis and Melanomagenesis. Lee KJ; Soyer HP; Stark MS J Invest Dermatol; 2024 Mar; 144(3):456-465. PubMed ID: 37921715 [TBL] [Abstract][Full Text] [Related]
59. Congenital melanocytic nevi: treatment modalities and management options. Marghoob AA; Borrego JP; Halpern AC Semin Cutan Med Surg; 2007 Dec; 26(4):231-40. PubMed ID: 18395671 [TBL] [Abstract][Full Text] [Related]
60. The relationship between melanocytic nevi and malignant melanoma. Friedman RJ; Rigel DS; Heilman ER Dermatol Clin; 1988 Apr; 6(2):249-56. PubMed ID: 3378371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]